Related references
Note: Only part of the references are listed.Breast cancer vaccines: Heeding the lessons of the past to guide a path forward
Cinzia Solinas et al.
CANCER TREATMENT REVIEWS (2020)
Evaluation of a panel of tumor-associated antigens in breast cancer
Cecilia Pagaza-Straffon et al.
CANCER BIOMARKERS (2020)
Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort
Samantha Puvanesarajah et al.
CANCER CAUSES & CONTROL (2020)
DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma
Guiji Zhang et al.
ONCOGENE (2020)
Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis
Makoto Kobayashi et al.
CANCERS (2020)
Whole Genome-Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non-Small-Cell Lung Cancer
Yuanqing Yan et al.
CANCER RESEARCH (2019)
Calcifications at Digital Breast To-mosynthesis: Imaging Features and Biopsy Techniques
Joao Horvat et al.
RADIOGRAPHICS (2019)
Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets
Sasha E. Stanton et al.
VACCINE (2019)
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
Peter F. McAnena et al.
BMC CANCER (2018)
Cancer vaccine strategies: translation from mice to human clinical trials
Jay A. Berzofsky et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection
Olga Kostianets et al.
BIOMARKERS (2017)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study
Aziza Nassar et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis
Hiroyuki Katayama et al.
CANCER RESEARCH (2015)
Designing vaccines to prevent breast cancer recurrence or invasive disease
Sasha E. Stanton et al.
IMMUNOTHERAPY (2015)
Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models
Ekram Gad et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study
Lynn C. Hartmann et al.
CANCER PREVENTION RESEARCH (2014)
Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer
Jianning Mao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer
Christine G. Joseph et al.
SCIENCE (2014)
Autoantibody Signatures Involving Glycolysis and Splicesome Proteins Precede a Diagnosis of Breast Cancer among Postmenopausal Women
Jon J. Ladd et al.
CANCER RESEARCH (2013)
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
Nuran Bektas Serce et al.
BMC CANCER (2012)
Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera
Hailing Lu et al.
CANCER PREVENTION RESEARCH (2012)
Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability
Chang Hyeok An et al.
HUMAN PATHOLOGY (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Functional genomics identifies therapeutic targets for MYC-driven cancer
Masafumi Toyoshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The molecular pathology of breast cancer progression
Alessandro Bombonati et al.
JOURNAL OF PATHOLOGY (2011)
Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women
Caroline Desmetz et al.
CLINICAL CANCER RESEARCH (2009)
Humoral response to cancer as a tool for biomarker discovery
C. Desmetz et al.
JOURNAL OF PROTEOMICS (2009)
Immunodominant HIV-1 Cd4+T Cell Epitopes in Chronic Untreated Clade C HIV-1 Infection
Danni Ramduth et al.
PLOS ONE (2009)
Insulin-like Growth Factor-Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer
Kyong Hwa Park et al.
CANCER RESEARCH (2008)
Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast
Logan C. Walker et al.
CANCER GENETICS AND CYTOGENETICS (2007)
In vivo selection for metastasis promoting genes in the mouse
Kiranmai Gumireddy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
The tumor antigen repertoire identified in tumor-bearing Neu transgenic mice predicts human tumor antigens
Hailing Lu et al.
CANCER RESEARCH (2006)
Immunoediting of cancers may lead to epithelial to mesenchymal transition
Keith L. Knutson et al.
JOURNAL OF IMMUNOLOGY (2006)
Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens
J Qiu et al.
JOURNAL OF PROTEOME RESEARCH (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)/SV40 Large T-antigen transgenic mouse model
RG Holzer et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Share Paper
